Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions

NCT04145570 is registered in ClinicalTrials.gov with Quadras Scientific Solutions as lead sponsor.

NCT NCT04145570
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04145570 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Dose,ComparativeBioavailability Study ofTwo Formulations ofErlotinib150mgTabletsunderFastingConditions
Lead sponsor
Quadras Scientific Solutions
Phase
Phase 4
Overall status
Completed
Start date
October 23, 2008
Completion date
November 9, 2008
Enrollment
24 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer